Sun, Jan 25, 2015, 7:58 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Neuralstem, Inc. Message Board

  • joejoepepitone joejoepepitone Apr 28, 2014 10:26 AM Flag

    CUR and BCLI are #1, #2 ALS Stem Cell Picks

    BCLI now officially #2. Today announced Phase 2 FDA Approval for testing at MAYO, Mass General , and U.Mass. Both companies will be big winners. CUR may have a slight lead timewise, but BCLI has opportunity for greater capital appreciation as it becomes more widely known and appreciated.

 
CUR
3.12-0.010(-0.32%)Jan 23 4:01 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.